Biostatistics School of Public Health
  1. Home
  2. News & Events
  3. Reflections on FDA Draft Guidance on Bayesian Methods in Trials—Protecting Scientific Integrity and Evidentiary Standards

Reflections on FDA Draft Guidance on Bayesian Methods in Trials—Protecting Scientific Integrity and Evidentiary Standards

JAMA Perspective

University of Washington Professor of Biostatistics Thomas Fleming and Affiliate Professor Holly Hanes reflect on the FDA's recently released draft guidance regarding the use of bayesian methods in clinical trials. 

https://jamanetwork.com/journals/jama/fullarticle/2847013?resultClick=1
Category
Faculty Intranet News
Research
Teaser Image
Thomas Fleming_500x500.png